Jump to content

Novozymes: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Line 50: Line 50:
* 1941 Novo launches its first enzyme, trypsin, extracted from the [[pancreas]] of animals and used to soften leather.
* 1941 Novo launches its first enzyme, trypsin, extracted from the [[pancreas]] of animals and used to soften leather.
* 1963 Alcalase – Novo’s first detergent enzyme produced by [[Industrial fermentation|fermentation]].
* 1963 Alcalase – Novo’s first detergent enzyme produced by [[Industrial fermentation|fermentation]].
* 1984 Launch of Maltogenase for the starch industry. The world’s first enzyme for industrial use produced by [[genetically modified organisms]].
* 1984 Launch of Maltogenase® for the starch industry. The world’s first enzyme for industrial use produced by [[genetically modified organisms]].
* 1987 Launch of Lipolase®. The world's first fat-splitting enzyme for detergents manufactured with genetically engineered microorganisms.
* 1987 Launch of Lipolase®. The world's first fat-splitting enzyme for detergents manufactured with genetically engineered microorganisms.
* 2000 Novo splits into three separate companies operating under the umbrella of the Novo Group: Novo A/S, [[Novo Nordisk|Novo Nordisk A/S]], and Novozymes A/S. Initial offering of Novozymes shares: DKK 150. Revenue (turnover) in year 2000: DKK 5,033 million.
* 2000 Novo splits into three separate companies operating under the umbrella of the Novo Group: Novo A/S, [[Novo Nordisk|Novo Nordisk A/S]], and Novozymes A/S. Initial offering of Novozymes shares: DKK 150. Revenue (turnover) in year 2000: DKK 5,033 million.

Revision as of 09:49, 10 September 2010

Novozymes A/S
Company typePublicly-traded Aktieselskab (Nasdaq Copenhagen: NZYM B)
IndustryBiotechnology
Founded1925
HeadquartersBagsværd, Denmark
Key people
Henrik Gürtler (Chairman), Steen Riisgaard (President and CEO)
ProductsEnzymes, microorganisms
RevenueDKK 8.448 billion (2009)[1]
DKK 1.688 billion (2009)[1]
DKK 1.194 billion (2009)[1]
Total assets27,983,000,000 Danish krone (2022) Edit this on Wikidata
Number of employees
5,275 (2009)[1]
Websitewww.novozymes.com

Novozymes is a biotech-based company and the world’s largest producer of industrial enzymes, with a market share of approximately 47% (2009)[2]. Novozymes markets approximately 700 different products worldwide.

Novozymes is headquartered in Denmark and employs approximately 5,300 people in 30 countries. Novozymes A/S’ B shares are listed on the NASDAQ OMX Nordic.

Business areas

Novozymes’ business is divided into three main areas: Enzymes for industrial use, Microorganisms and Biopharmaceutical Ingredients accounting for respectively 92%, 5% and 3% of sales (2009). Novozymes invested 14.3% of sales in research and development in 2009.

Enzymes

Enzymes are divided into the following categories:

  • Detergent enzymes. For use in laundry detergents and automatic dish washing machines.
  • Technical enzymes. The most important products in this business area are enzymes for the starch, textile and bioethanol industries, as well as enzymes for the leather and forest products industries and various other smaller industries.
  • Food enzymes. Food enzymes include products for the baking, brewing, beverage alcohol, fruit juice and wine industries, and other food industries such as the dairy industry and the oils & fats industry.
  • Feed enzymes. Includes enzymes for the animal feed industries.

Biopharmaceuticals

Biopharmaceutical ingredients comprise of regulatory-compliant, protein based products and technologies dedicated to the biopharmaceutical industry, adding value through efficiency - from manufacture to final drug formulation and drug delivery.

Microorganisms

The microorganisms business area includes microorganisms for institutional and household cleaning, wastewater treatment, aquaculture, plant care etc.

Ownership

The Novozymes A share capital is held by Novo A/S, a wholly-owned subsidiary of the Novo Nordisk Foundation. In addition, Novo A/S holds 5,826,280 B shares, which overall gives Novo A/S 25.5% of the total share capital and 70.1% of the votes.

Novozymes A/S' B shares are listed on the NASDAQ OMX Nordic and are traded under the abbreviated name NZYM B and the ID code/ISIN DK0010272129. The B shares are issued in units of DKK 10.

Each A share carries the right to cast one hundred votes at the company's shareholders' meeting, each B share the right to cast ten votes.

Timeline

  • 1925 Novo Terapeutisk Laboratorium (hereafter called Novo) founded with the aim to produce insulin.
  • 1941 Novo launches its first enzyme, trypsin, extracted from the pancreas of animals and used to soften leather.
  • 1963 Alcalase – Novo’s first detergent enzyme produced by fermentation.
  • 1984 Launch of Maltogenase® for the starch industry. The world’s first enzyme for industrial use produced by genetically modified organisms.
  • 1987 Launch of Lipolase®. The world's first fat-splitting enzyme for detergents manufactured with genetically engineered microorganisms.
  • 2000 Novo splits into three separate companies operating under the umbrella of the Novo Group: Novo A/S, Novo Nordisk A/S, and Novozymes A/S. Initial offering of Novozymes shares: DKK 150. Revenue (turnover) in year 2000: DKK 5,033 million.
  • 2001 Novozymes launch a new business strategy, expanded to include initiatives outside the core enzyme business.
  • 2003 Novozymes buys five smaller companies to form microorganism business unit.
  • 2007 Novozymes forms new biopharmaceutical ingredients business unit based on the acquisitions of three smaller companies.
  • 2009 Novozymes share price at year-end: DKK 540.

References and footnotes

  1. ^ a b c d "Annual Report 2009" (PDF). Novozymes. Retrieved 2010-04-02.
  2. ^ Novozymes Annual Report 2009
Retrieved from "https://en.wikipedia.org/w/index.php?title=Novozymes&oldid=383996307"